Your browser doesn't support javascript.
loading
Homologous and heterologous re-challenge with Salmonella Typhi and Salmonella Paratyphi A in a randomised controlled human infection model.
Gibani, Malick M; Jin, Celina; Shrestha, Sonu; Moore, Maria; Norman, Lily; Voysey, Merryn; Jones, Elizabeth; Blackwell, Luke; Thomaides-Brears, Helena; Hill, Jennifer; Blohmke, Christoph J; Dobinson, Hazel C; Baker, Philip; Jones, Claire; Campbell, Danielle; Mujadidi, Yama F; Plested, Emma; Preciado-Llanes, Lorena; Napolitani, Giorgio; Simmons, Alison; Gordon, Melita A; Angus, Brian; Darton, Thomas C; Cerundulo, Vincenzo; Pollard, Andrew J.
Afiliação
  • Gibani MM; Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, United Kingdom.
  • Jin C; Department of Infectious Diseases, Imperial College London, United Kingdom.
  • Shrestha S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, United Kingdom.
  • Moore M; Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, United Kingdom.
  • Norman L; Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, United Kingdom.
  • Voysey M; Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, United Kingdom.
  • Jones E; Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, United Kingdom.
  • Blackwell L; Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, United Kingdom.
  • Thomaides-Brears H; Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, United Kingdom.
  • Hill J; Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, United Kingdom.
  • Blohmke CJ; Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, United Kingdom.
  • Dobinson HC; Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, United Kingdom.
  • Baker P; Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, United Kingdom.
  • Jones C; Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, United Kingdom.
  • Campbell D; Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, United Kingdom.
  • Mujadidi YF; Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, United Kingdom.
  • Plested E; Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, United Kingdom.
  • Preciado-Llanes L; Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, United Kingdom.
  • Napolitani G; Institute for Infection and Global Health, University of Liverpool, United Kingdom.
  • Simmons A; Medical Research Council Human Immunology Unit, Radcliffe Department of Medicine, University of Oxford, United Kingdom.
  • Gordon MA; Medical Research Council Human Immunology Unit, Radcliffe Department of Medicine, University of Oxford, United Kingdom.
  • Angus B; Medical Research Council Human Immunology Unit, Radcliffe Department of Medicine, University of Oxford, United Kingdom.
  • Darton TC; Institute for Infection and Global Health, University of Liverpool, United Kingdom.
  • Cerundulo V; Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi.
  • Pollard AJ; Nuffield Department of Medicine, University of Oxford, United Kingdom.
PLoS Negl Trop Dis ; 14(10): e0008783, 2020 10.
Article em En | MEDLINE | ID: mdl-33079959
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Salmonella paratyphi A / Salmonella typhi / Febre Tifoide / Febre Paratifoide Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies Limite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Salmonella paratyphi A / Salmonella typhi / Febre Tifoide / Febre Paratifoide Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies Limite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article